ATR:NYE-AptarGroup Inc. (USD)

EQUITY | Medical Instruments & Supplies | New York Stock Exchange

Last Closing

USD 149.35

Change

+0.79 (+0.53)%

Market Cap

USD 4.78B

Volume

0.31M

Analyst Target

USD 125.86
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

AptarGroup, Inc., is a solution provider of packaging delivery solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-27 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 65.91B
ALC Alcon AG

N/A

USD 46.01B
RMD ResMed Inc

N/A

USD 34.14B
BAX Baxter International Inc

N/A

USD 18.71B
AVTR Avantor Inc

N/A

USD 11.92B
TFX Teleflex Incorporated

N/A

USD 6.39B
STVN Stevanato Group SpA

N/A

USD 5.88B
BLCO Bausch + Lomb Corp

N/A

USD 5.64B
WRBY Warby Parker Inc

N/A

USD 2.55B
INFU InfuSystems Holdings Inc

N/A

USD 0.13B

ETFs Containing ATR

NBSM Neuberger Berman ETF Trus.. 2.58 % 0.00 %

N/A

USD 0.21B
FCUL:CA 0.00 % 0.00 %

N/A

N/A
XMLV Invesco S&P MidCap Low Vo.. 0.00 % 0.25 %

N/A

USD 0.77B
HSMV First Trust Horizon Manag.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.93% 61% D- 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.93% 61% D- 27% F
Trailing 12 Months  
Capital Gain 3.79% 78% C+ 60% D-
Dividend Return 0.91% 67% D+ 19% F
Total Return 4.70% 78% C+ 51% F
Trailing 5 Years  
Capital Gain 58.88% 80% B- 54% F
Dividend Return 7.87% 83% B 15% F
Total Return 66.76% 87% B+ 46% F
Average Annual (5 Year Horizon)  
Capital Gain 5.92% 63% D 55% F
Dividend Return 7.08% 63% D 52% F
Total Return 1.16% 60% D- 27% F
Risk Return Profile  
Volatility (Standard Deviation) 21.35% 74% C 50% F
Risk Adjusted Return 33.17% 95% A 48% F
Market Capitalization 4.78B 64% D 86% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Instruments & Supplies) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 24.10 73% 26%
Price/Book Ratio 4.07 29% 21%
Price / Cash Flow Ratio 15.79 57% 25%
Price/Free Cash Flow Ratio 14.02 69% 31%
Management Effectiveness  
Return on Equity 15.57% 92% 77%
Return on Invested Capital 17.74% 79% 84%
Return on Assets 7.20% 93% 88%
Debt to Equity Ratio 1,439.44% 10% 2%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector